GeneArrest Overview

  • Founded
  • 2009
  • Status
  • Out of Business
  • Employees
  • 11
  • Latest Deal Type
  • Out of Business

GeneArrest General Information


Developer of an anti-gene drug platform. The company develops a computational design of modular polymers that bind a specific sequence of DNA.

Contact Information

Formerly Known As
Antigene Biotechnologies
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • POB 1252, Nazareth Industrial Area
  • NGT incubator, Sami Shahin building
  • Nazareth 16000
  • Israel
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GeneArrest Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business Completed Out of Business
1. Accelerator/Incubator Completed Generating Revenue
To view GeneArrest’s complete valuation and funding history, request access »

GeneArrest Executive Team (3)

Name Title Board Seat Contact Info
Mizied Falah Ph.D Co-Founder & Chief Technology Officer
Anwar Rayan Ph.D Co-Founder & Chief Executive Officer
To view GeneArrest’s complete executive team members history, request access »

GeneArrest Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial